Skip to main content
. 2012 Feb 29;41(2):15–26.

Table 2:

Prevalence (%) of metabolic abnormalities associated with serum aminotransferase levels

Metabolic Abnormalities Alanine aminotransferase, IU/L
P for trend Aspartate aminotransferase, IU/L
P for trend
<20 20–29 30–39 40–49 ≥50 <20 20–29 30–39 40–49 ≥50
Men
Hypertension-positive 37.32 45.70 54.62 53.70 57.33 0.01 39.50 45.54 50.25 50.79 63.64 0.01
Central obesity 18.60 34.00 44.96 54.63 63.33 0.01 27.12 31.87 38.58 44.44 63.64 0.01
Triglyceride ≥1.7(mmol/L) 20.44 35.54 49.58 56.48 64.67 0.01 25.39 33.82 47.72 61.90 70.45 0.01
HDL-cholesterol<1.3 mmol/L 53.57 57.84 54.62 62.96 64.67 0.01 58.62 56.04 51.78 50.79 56.82 0.11
Glucose >5.6 (mmol/L) 19.95 23.40 26.47 32.41 32.00 0.01 23.82 22.71 22.34 25.40 36.36 0.35
Women
Hypertension-positive 31.64 43.97 43.54 51.52 56.72 0.01 31.49 38.26 47.96 63.27 51.52 0.01
Central obesity 34.25 50.94 68.52 74.24 67.16 0.01 36.39 43.43 52.04 83.67 63.64 0.01
Triglyceride ≥1.7 (mmol/L) 22.19 33.78 43.52 46.97 55.22 0.01 23.32 28.91 33.67 65.31 42.42 0.01
HDL-cholesterol<1.3 (mmol/L) 46.23 42.90 44.44 48.48 53.73 0.57 49.55 41.29 37.76 48.98 51.52 0.03
Glucose >5.6 (mmol/L) 11.99 17.16 13.89 18.18 14.93 0.04 13.07 12.63 16.33 20.41 18.18 0.16

HDL, high density lipoprotein;